Medline shares opened at $35 each, versus the IPO price of $29, after the medical supplier raised $6.26 billion in the year's biggest initial public offering. Bailey Lipschultz reports on Bloomberg Television. ...

The IPO of the year, the biggest one, uh, popping on its open last hours, just a few minutes ago, really after some middling performance in the IPO market generally. Is it a sign of pent-up demand into mega offerings like SpaceX next year. A sigh of relief for the private equity space, too.Leslie Picker has more over at the NASDAQ. Leslie, hey, Kelly, [music] yes. The largest IPO of the year, Medline, opening for trading about 15 minutes ago at $35 per share.That's up more than 20% from its IPO price of $29 ...

Key Takeaways Shares of medical supply company Medline soared in their trading debut on the Nasdaq Wednesday.The company raised more than $6 billion with the sale of 216 million shares priced at $29 each, making its the largest U.S. IPO in terms of proceeds since Rivian's in 2021. Medline shares surged in their trading debut Wednesday, after the medical supply company raised $6.26 billion in one of the biggest initial public offerings in recent years.  The stock, which trades under the "MDLN" stock tic ...

Shares of Medline opened 20.7% above their offer price in their Nasdaq debut on Wednesday, giving the medical supply giant a valuation of $46.03 billion. ...

Key Takeaways Medical supply company Medline is set to make its trading debut on the Nasdaq today.The company raised more than $6 billion with the sale of 216 million shares priced at $29 each, making its the largest U.S. IPO in terms of proceeds since Rivian's in 2021. Medline is set to start trading on the Nasdaq today, after the medical supply company raised $6.26 billion in one of the biggest initial public offerings in recent years.  The medical supply giant, which will debut under the "MDLN" stoc ...

Medline Inc. shares surged 41% in their trading debut, after the medical supplier raised $6.26 billion in the year’s biggest initial public offering. The shares closed at $41 each on Wednesday in New York, versus the IPO price of $29. Medline, which counts Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman among its backers, sold 216 million shares in an upsized offering that priced near the top of the marketed range. Most Read from Bloomberg The trading gives the company a market value of abou ...

U.S. medical supplies giant Medline is set to debut on the Nasdaq on Wednesday after the biggest initial public offering of the year. The private equity-owned company priced at $29 per share on Tuesday, raising $6.26 billion in an upsized offering that finishes off a strong year for new listings and bolsters optimism about the IPO market in 2026. Shares of Medline will trade under the symbol "MDLN." The IPO pricing gives Medline a market value of at least $37 billion, based on the shares listed in its regul ...

It's been a tumultuous year for U.S. stock markets. Investors have had their nerves rattled twice this year by government-related events—President Trump's Liberation Day tariffs in the spring, followed by the longest U.S. government shutdown in history this fall. That's on top of an economy already hit hard by inflation and declining consumer confidence. Yet despite this, there have still been several high-profile and successful initial public offerings throughout the year—especially in the AI and fintech s ...

Smith Collection / Gado / Getty Images Medline says it supplies more than 330,000 medical products to hospitals around the world Key Takeaways Shares of medical supply company Medline soared in their trading debut on the Nasdaq Wednesday. The company raised more than $6 billion with the sale of 216 million shares priced at $29 each, making its the largest U.S. IPO in terms of proceeds since Rivian's in 2021. Medline shares surged in their trading debut Wednesday, after the medical supply company rai ...

Medline stock made a blockbuster debut on Wednesday with its IPO listing at $29 per share. The company raised roughly $6.26 billion and hit the public markets with an implied valuation near $50 billion, making it the year's biggest listing. The Northfield, Illinois-based medical-supplies giant, backed by Blackstone, Carlyle, and Hellman & Friedman, upsized the deal to meet robust institutional demand. Opening trades suggested the stock could gap higher on day one. But investors need to focus on some critica ...